Lamivudine Tablets

Lamivudine is presented as tablets and belongs to the class of nucleoside reverse transcriptase inhibitor. Its standard indications include hIV-1 infection and chronic hepatitis B, as determined by a prescribing clinician.

Specifications are indicative; availability, composition, pack sizes and registration requirements may vary by destination market.